Abvance Receives $3.9M to Support Diabetes Therapeutic | StartUp Health Insights: Week of Sep 10, 2024
Abvance Therapeutics has received a Program Related Investment from The Helmsley Charitable Trust to support development of its novel insulin and glucagon combined formulation.
This week, Abvance Therapeutics – a member of StartUp Health’s T1D Moonshot Community – announced a $3.9M Program Related Investment from The Leona M. and Harry B. Helmsley Charitable Trust. The PRI will support the pre-clinical development of ABV100, Abvance’s proprietary, clinically-validated combination of insulin and glucagon with a goal of improving glycemic control while reducing hypoglycemia for people with diabetes who require rapid-acting insulin. <source>
Other health innovation funding reported this week included:
Superluminal Medicines, a Boston, MA-based company that uses generative biology, chemistry, and machine learning approaches to create medicines, raised $120M led by RA Capital Management, with participation from Insight Partners, NVentures (NVIDIA’s venture capital arm), Gaingels, Catalio Capital Management, Eli Lilly and Company, and Cooley. <source>
Qualifyze, a Frankfurt, Germany-based company that specializes in supply chain risk management for the life sciences industry, raised $54M led by Insight Partners, with participation from HV Capital, HarbourVest Partners, H14, and Cherry Ventures. <source>
CorFlow Therapeutics, a Baar, Switzerland-based company focused on diagnostic and therapeutic solutions for restoring healthy microvascular blood flow, raised €44M ($48.5M) co-led by Broadview Ventures and Panakes Partners, with participation from 415 Capital, Merieux Equity Partners, Laerdal Million Lives Fund, Wellington Partners, M&L Investments, Unorthodox Ventures, KOFA Healthcare, and Monte Carlo Capital. <source>
Thatch, a San Francisco, CA-based employer-focused health benefits platform, raised $38M led by General Catalyst and Index Ventures, with participation from SemperVirens, the General Partnership, Andreessen Horowitz (a16z), and Avid Ventures. <source>
Viome Life Sciences, a Bellevue, WA-based startup developing microbiome products and health diagnostic tools, raised $25M from Khosla Ventures, Marc Benioff, Bold Capital WRG Ventures, and others. <source>
Sounder Benefits, a Boise, ID-based healthtech startup that provides total benefit solutions for high-growth companies, raised $7.5M from undisclosed inventors. <source>
CardiaTec, a Cambridge, UK-based startup employing AI to decode the biology behind cardiovascular disease, raised $6.5M led by Montage Ventures, with participation from Laidlaw Scholars Ventures, Apex Ventures, and Continuum Health Ventures. <source>
Constantiam Biosciences, a Houston, TX-based startup focused on powering genomic medicine, received a $2.05M Phase II SBIR grant from the National Human Genome Research Institute (NHGRI). <source>
Bone Index, a Kuopio, Finland-based medical technology company focused on bone health diagnostics, raised an undisclosed amount led by Lynx Financial. <source>
CancerIQ, a Chicago, IL-based precision health platform that empowers healthcare providers to personalize cancer prevention and early detection for their patients, raised an undisclosed amount from Decathlon Capital Partners. <source>
CuraLinc Healthcare, a Chicago, IL-based provider of employee assistance (EAP), student, and workforce mental health programs, raised an undisclosed amount from Lightyear Capital. <source>
Curio Digital Therapeutics, a Princeton, NJ-based developer of digital therapeutics for postpartum depression (PPD) and other women’s mental health conditions, raised an undisclosed amount from RYSE Asset Management, ONCE, Bridge Point Capital, and Avestria. <source>
Forge Health, a New York, NY-based outpatient mental health and substance use care provider, raised an undisclosed amount from MFO Ventures. <source>
GoChallenge, a Dublin, Ireland-based provider of an employee engagement platform focused on promoting health and wellness, raised an undisclosed amount from John O’Shea. <source>
MyndYou, a New York, NY-based provider of conversational AI solutions for healthcare, raised an undisclosed amount from WindRose Health. <source>
neuro42, a San Francisco, CA-based developer of portable MRI systems for neuroimaging and interventions, raised an undisclosed amount from Zynext Ventures. <source>
Data is from StartUp Health Insights, the most comprehensive funding database for health innovation. Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.
Call for Alzheimer’s Innovation
With support from the Alzheimer’s Drug Discovery Foundation (ADDF) and Gates Ventures, we’ve launched a new global initiative created to develop a collaborative innovation community alongside leading companies, research teams, and stakeholders with a mission to accelerate progress in prevention, diagnosis, and management of Alzheimer’s disease and related dementias. Learn more and apply for an Alzheimer’s Moonshot Fellowship.
Follow us on social media for daily updates on Health Transformers: X (Twitter), LinkedIn, Facebook, and Instagram.